|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| G01N 33/68 | (2006.01) | ||
| A61K 47/00 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3354277 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18161509.7 |
| Date of filing the European patent application | 2010-07-28 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 22919509 P | 2009-07-28 | US | |
| 30304410 P | 2010-02-10 | US | |
| 31751310 P | 2010-03-25 | US | |
| 33337210 P | 2010-05-11 | US | |
| 35933810 P | 2010-06-28 | US |
| (72) |
DANIEL, Peter, F. , US
HEARTLEIN, Michael, W. , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE |
| COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE |